SURMOUNT-5 was a phase 3b, open-label, controlled trial in 751 adults with obesity but without type 2 diabetes, randomized 1:1 to the maximum tolerated dose of tirzepatide (10 mg or 15 mg) or the maximum tolerated dose of semaglutide (1.7 mg or 2.4 mg), once weekly for 72 weeks
This approach is ideal for individuals who have struggled with traditional weight loss methods or want a structured, medically guided plan
Microdosing GLP-1 medications means taking smaller-than-standard doses of drugs like semaglutide or tirzepatide, often below the amounts used in clinical trials or official prescribing guidelines
I need to redirect myself. Its quite interesting, and its very complicated. GP and bariatric physician Lara Courtenay, a MAS Member who works with the Weightless specialist team at MacMurray Centre
Persistent headaches that worsen over time instead of improving deserve professional evaluation
3.6 mg Niacin (as Niacin, Niacinamide)